[ Price : $8.95]
FDA approves an Instylla PMA for its Embrace Hydrogel Embolic System, a liquid embolic device for treating hypervascular tumors in...[ Price : $8.95]
FDA says it will allow up to 12 months for doctors to transition patients who are taking unapproved animal-derived thyroid medicat...[ Price : $8.95]
Eli Lilly says it will file an NDA by the end of the year for its investigational obesity treatment orforglipron, based on just-an...[ Price : $8.95]
FDA warns Taiwans Visgeneer, Inc., about Quality System and Medical Device Reporting violations in its manufacturing of blood gluc...[ Price : $8.95]
FDA issues an online post describing the safety to patients of the type of PFAS used in medical devices.[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb supplemental BLA for Breyanzi (lisocabtagene maraleucel; liso-cel) as a pot...[ Price : $8.95]
FDA accepts a Lantheus NDA for a new formulation of its Pylarify F 18 prostate-specific membrane antigen imaging agent.[ Price : $8.95]
FDA issues an early alert based on a Boston Scientific letter to customers about certain Endotak Reliance defibrillation leads tha...